期刊简介
《医学临床研究》由湖南省卫生厅主管、湖南省医学会主办，经国家新闻出版总署批准（中国连续出版物号ISSN1671-7171，CN43-1382/R）的医学临床类科技期刊。原名《湖南医学》，1984年10月创刊，由我国著名医学专家柳用墨教授任主编，1985年2月正式出版发行，2002年更名为《医学临床研究》由双月刊改为月刊。20多年来，本刊先后获得国家、省级一级一类优秀科技期刊奖多项，2000年入选中国期刊方阵（双效期刊），2002年4月再进入科技部中国科技论文统计源期刊，入编《中国学术期刊光盘版》，被万方数据库全文收录。本刊的宗旨是：注重学术，讲求质量，力创精品，为医学临床事业和广大科技工作者服务。设有论著、临床研究（含药物与临床、检验与临床、医学影像、麻醉等）、诊疗经验、护理园地、病例报告、医院管理等常规栏目，间有院士（专家）论坛、院长笔谈、述评及专题论述等特色栏目。目前稿源已涉及全国各省、市（区）及香港特区。 《医学临床研究》为月刊，每月26日出版，大16开本，192页，铜板纸印刷，每期定价15.00元，全年12期，国内外公开发行，邮发代号42-13，全国各地邮局均可订阅，编辑部亦可办理邮购。邮局汇款：湖南省长沙市湘雅路30号（省卫生厅内）医学临床研究杂志社，邮编410008。银行汇款：开户名称：医学临床研究杂志社开户银行：中国银行长沙市湘雅支行开户账号：610657349900Email:jcr_cs.hn@vip.163.com网址： http://www.jcr.net.cn联系电话（传真）：0731-84824007。
亚太热带医药杂志（英文版）征稿启事
时间：2023-08-11 10:34:00
Asian Pacific Journal of Tropical Medicine《亚太热带医学杂志（英文版）》（月刊），创刊于2008年，由海南医学院主办、国际著名出版集团Elsevier(爱思唯尔)出版、发行，是目前中国唯一一本全英文版的国际性热带医药期刊（月刊）。
Instructions to Authors
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Asian Pacific Journal of Tropical Medicine alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the Asian Pacific Journal of Tropical Medicine readers are also liable to be rejected at this stage itself.
Manuscripts that are found suitable for publication in Asian Pacific Journal of Tropical Medicine are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Manuscripts received from Editorial Board members will be screened by the Executive Editor-in-Chief and sent to external peer reviewers. The editorial board members who are authors will be excluded from publication decisions.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately on acceptance.